In Vivo Cell Engineering using oRNA®
Time: 2:15 pm
day: Conference Day Two
Details:
- Orna is leveraging its groundbreaking circular RNA technology paired with its extensive LNP delivery platform to enable the next generation of in vivo cell therapies
- Featuring robust delivery of oRNA to immune cells enabling in vivo CAR mediated depletion of target B cells in vivo
- Demonstrating key progress showing in vivo editing of hematopoietic stem cells to enable development of novel therapies for the hemoglobinopathies and beyond
